Feedback / Questions
ETX-810 - Eliem Therap
https://www.globenewswire.com/news-release/2022/06/27/2469886/0/en/Eliem-Therapeutics-Announces-Last-Patient-Completed-Dosing-in-Phase-2a-Study-of-ETX-810-in-Patients-with-Lumbosacral-Radicular-Pain-LSRP.html
Jun 27, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next